Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glaxo wellcome production - franta - fluticasonum propionat+umeclidinium+vilanterol - pulb. de inhal. unidoza - 92micrograme/55micrograme/22micrograme

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - boala pulmonară, obstructivă cronică - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - boala pulmonară, obstructivă cronică - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - boala pulmonară, obstructivă cronică - formoterol și bromura de glicopironiu - bevespi aerosphere este indicat în tratamentul bronhodilatator de întreținere pentru ameliorarea simptomelor la pacienții adulți cu boală pulmonară obstructivă cronică (bpoc).